Solid Biosciences (SLDB) Leases (2019 - 2024)
Historic Leases for Solid Biosciences (SLDB) over the last 6 years, with Q3 2024 value amounting to $24.9 million.
- Solid Biosciences' Leases fell 856.96% to $24.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $24.9 million, marking a year-over-year decrease of 856.96%. This contributed to the annual value of $26.5 million for FY2023, which is 832.5% down from last year.
- Solid Biosciences' Leases amounted to $24.9 million in Q3 2024, which was down 856.96% from $25.5 million recorded in Q2 2024.
- Over the past 5 years, Solid Biosciences' Leases peaked at $28.9 million during Q4 2022, and registered a low of $722000.0 during Q1 2022.
- Over the past 5 years, Solid Biosciences' median Leases value was $24.9 million (recorded in 2024), while the average stood at $15.6 million.
- In the last 5 years, Solid Biosciences' Leases crashed by 7740.93% in 2022 and then surged by 382049.86% in 2023.
- Quarter analysis of 5 years shows Solid Biosciences' Leases stood at $3.6 million in 2020, then plummeted by 68.09% to $1.1 million in 2021, then surged by 2434.94% to $28.9 million in 2022, then decreased by 8.32% to $26.5 million in 2023, then fell by 6.33% to $24.9 million in 2024.
- Its Leases stands at $24.9 million for Q3 2024, versus $25.5 million for Q2 2024 and $26.1 million for Q1 2024.